Zolinza (vorinostat) is an anticancer medication used to treat skin problems in adults with cutaneous T-cell lymphoma (CTCL) when other treatments haven't worked or the condition has come back. It's a type of medication called a histone deacetylase (HDAC) inhibitor. You take Zolinza (vorinostat) by mouth, usually 400 mg once a day with food. Some common side effects include tiredness, nausea, and diarrhea.
In some cancer cells, such as lymphoma cells, certain proteins help send messages that tell the cells to grow and spread. One of these proteins is called histone deacetylase (HDAC).
Zolinza (vorinostat) is a histone deacetylase (HDAC) inhibitor. It blocks the histone deacetylase protein, which stops it from sending messages to the cell. When this protein is blocked, cancer cells don’t grow and spread as well.
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Contact your healthcare provider immediately if you experience any of the following.
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur:
More common
black, tarry stools
bleeding gums
bloating or swelling of the face, arms, hands, lower legs, or feet
blood in the urine or stools
body aches or pain
chills
confusion
decreased urine
dizziness or lightheadedness
ear congestion
fainting
fast or irregular heartbeat
headache
increased thirst
large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or genitals
loss of appetite
loss of voice
lower back or side pain
mood changes
muscle pain or cramps
no blood pressure
no breathing
no pulse
numbness or tingling in the face, lips, arms, hands, feet, or legs
pain, redness, or swelling in the arm or leg
painful or difficult urination
pale skin
pinpoint red spots on the skin
rapid weight gain
seizures
sores, ulcers, or white spots on the lips or in the mouth
swollen glands
trouble speaking, thinking, or walking
troubled breathing
troubled breathing with exertion
unusual bleeding or bruising
unusual drowsiness, dullness, tiredness, weakness, or feeling of sluggishness
vomiting
Less common
Persistent non-healing sore
pink growth
reddish patch or irritated area
shiny bump
white, yellow, or waxy scar-like area
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
Sort of. Zolinza (vorinostat) can be considered a type of chemotherapy. But it works differently from traditional chemotherapy medications, which directly attacks all fast-growing cells (including healthy cells). Zolinza (vorinostat) is histone deacetylase (HDAC) inhibitor and it targets cancer cells by blocking a specific protein that cancer cells typically depend on to grow and spread. Research suggests it isn't likely to affect healthy cells. This makes Zolinza (vorinostat) a more targeted therapy compared to traditional chemotherapy.
Let your oncology team know if you have diabetes. Since Zolinza (vorinostat) can raise blood sugar levels, they might adjust your diabetes medications or recommend checking your blood sugar more often to keep it under control. Track your blood sugar levels by writing down your numbers and bringing them to your appointments so your care team has a better idea of how the medication is affecting your body. Tell your healthcare team if you notice symptoms of high blood sugar levels, like feeling really thirsty, tired, or needing to urinate more often.
Yes, Zolinza (vorinostat) can cause nausea and vomiting. Symptoms might be mild for some people, but more severe for others. It's important to take Zolinza (vorinostat) with food and to drink 8 glasses of water (at least 8 ounces per glass) daily while you're receiving treatment. Doing so might ease nausea or vomiting, and keep you hydrated if you do experience these side effects. Your oncologist might also prescribe an anti-nausea medication or recommend lifestyle changes to manage your symptoms. But if these side effects make it hard for you to take your medication or hold down food, let your oncology team know. They might lower your dose of Zolinza (vorinostat) or talk with you about other options.
Typically, your oncology team will ask you to take Zolinza (vorinostat) as long as it’s controlling the cutaneous T-cell lymphoma (CTCL) and you’re able to handle its side effects. They'll monitor how well the medication is working for you based on skin assessments and scans. Let your care team know about any side effects you experience. Don’t stop taking Zolinza (vorinostat) without first talking to your oncologist.
While it’s possible to lose some hair while taking Zolinza (vorinostat), this isn’t a common side effect. You might experience mild or moderate hair thinning or loss during treatment, but hair usually grows back after you stop taking the medication. Let your oncologist know if you have hair loss because there might also be other causes they want to look into.
Zolinza (vorinostat) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Though rare, some people taking Zolinza (vorinostat) developed blood clots, including deep vein thrombosis (DVT) and pulmonary embolism (PE). If you have swelling in one arm or one leg, sudden chest pain and sudden trouble breathing, seek medical help right away. These might be signs of a blood clot.
Zolinza (vorinostat) can cause your red blood cells (RBCs) and platelet levels to drop. Your RBCs carry oxygen through your body. So when their levels are low, you might feel tired and feel as if you can’t breathe as well.
Your platelets help clot blood. So when their levels are low, your body can’t stop bleeding as well. People taking other histone deacetylase inhibitors (HDACs), such as valproic acid, together with Zolinza (vorinostat) are at even higher risk for bleeding.
Your oncologist will monitor your RBC and platelet levels with a lab test called a complete blood count every 2 weeks for the first two months after you start Zolinza (vorinostat), then monthly after that. If your levels are too low, they might ask you to pause treatment or take a lower dose of the medication. Contact your oncology care team if you have unusual bruising or bleeding, or feel severe tiredness.
People taking Zolinza (vorinostat) have experienced nausea, vomiting, and diarrhea. Your oncologist might recommend an antiemetic medication for you to take to manage nausea or vomiting. Examples include ondansetron (Zofran) or prochlorperazine (Compazine). They might also recommend you meet with a dietician to discuss ways to eat to help prevent stomach upset.
If you experience diarrhea, there are several over-the-counter medications your healthcare team might recommend, such as loperamide (Imodium-AD). In addition, you should drink plenty of fluids to stay hydrated. Avoid sugary sports drinks because these can make diarrhea worse. If you have nausea, vomiting, or diarrhea that doesn’t get better with medications, contact your oncologist.
Some people taking Zolinza (vorinostat) have developed higher blood sugar levels (hyperglycemia). Most of the time, this change was mild, but about 5% of people who took Zolinza (vorinostat) in clinical studies experienced severely high blood sugar. Your oncologist will check your blood sugar with a blood test every 2 weeks during the first 2 months of treatment with Zolinza (vorinostat). If you have diabetes or have a history of high blood sugar, they might recommend you to monitor your blood sugar at home. If you have symptoms of dangerously high blood sugar, such as feeling very thirsty and urinating often, contact your oncologist right away.
Zolinza (vorinostat) hasn’t been studied in human pregnancy. But, based on animal studies and the way the medication works, it could harm an unborn baby and cause pregnancy loss (miscarriage). If you’re able to get pregnant, you should use effective birth control while you’re taking Zolinza (vorinostat) and for 6 months after the last dose. If you’re able to get your partner pregnant, you should use effective birth control such as condoms while taking Zolinza (vorinostat) and for 3 months after the last dose.
| Dosage | Quantity | Price as low as | Price per unit |
|---|---|---|---|
| 100mg | 120 capsules | $14,415.47 | $120.13 |
Adults: The typical dose is 400 mg by mouth once a day with food.
Your dose might be lower if you have liver problems or experience serious side effects.
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.
Using this medicine with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.
Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.